Cellular Biomedicine (CBMG) Stock Price, Quote, News and Overview

What is the stock price of Cellular Biomedicine today?

The current stock price of CBMG is 19.75 null.

What is the ticker symbol for Cellular Biomedicine stock?

The exchange symbol of Cellular Biomedicine is CBMG and it is listed on the Nasdaq exchange.

On which exchange is CBMG stock listed?

CBMG stock is listed on the Nasdaq exchange.

What is Cellular Biomedicine worth?

Cellular Biomedicine (CBMG) has a market capitalization of 384.69M null. This makes CBMG a Small Cap stock.

What are the support and resistance levels for Cellular Biomedicine (CBMG) stock?

Cellular Biomedicine (CBMG) has a support level at 19.27 and a resistance level at 19.76. Check the full technical report for a detailed analysis of CBMG support and resistance levels.

Should I buy Cellular Biomedicine (CBMG) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of CBMG, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of CBMG, evaluating the profitability, health, valuation and growth aspects
• Cellular Biomedicine (CBMG) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• Cellular Biomedicine (CBMG) Sales and EPS estimates to see what analysts future expectations are.
• Cellular Biomedicine (CBMG) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• Cellular Biomedicine (CBMG) Insider and Institutional Ownership to learn about the owners and their transactions.
• Cellular Biomedicine (CBMG) Stock Chart to make your own analysis
• Cellular Biomedicine (CBMG) Latest news and press-releases to stay up to date.

Does Cellular Biomedicine (CBMG) stock pay dividends?

CBMG does not pay a dividend.

What is the Price/Earnings (PE) ratio of Cellular Biomedicine (CBMG)?

Cellular Biomedicine (CBMG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.82).

ChartMill assigns a fundamental rating of 1 / 10 to CBMG. Both the profitability and financial health of CBMG have multiple concerns.

Over the last trailing twelve months CBMG reported a non-GAAP Earnings per Share(EPS) of -2.82. The EPS decreased by -17.01% compared to the year before.

ChartMill assigns a Buy % Consensus number of 60% to CBMG. The Buy consensus is the average rating of analysts ratings from 1 analysts.